Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy
University of California, San Diego
University of California, San Diego
M.D. Anderson Cancer Center
Brigham and Women's Hospital
Milton S. Hershey Medical Center
Emory University
Institut Cancerologie de l'Ouest
Boehringer Ingelheim
St. Joseph's Hospital and Medical Center, Phoenix
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Wake Forest University Health Sciences
Thomas Jefferson University
University of Wisconsin, Madison
Memorial Sloan Kettering Cancer Center
University of California, Davis
St. Joseph's Hospital and Medical Center, Phoenix
Thomas Jefferson University
Thomas Jefferson University
NYU Langone Health
University of Utah
National Cancer Institute (NCI)
Wake Forest University Health Sciences
University of Oxford
Medical University of South Carolina
Medical College of Wisconsin
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dartmouth-Hitchcock Medical Center
Five Prime Therapeutics, Inc.
University of Pittsburgh
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
University of Chicago
Abramson Cancer Center at Penn Medicine
University of Rochester
Duke University
Istari Oncology, Inc.
Stanford University
Wake Forest University Health Sciences
University of Nebraska
Translational Drug Development
Amgen
Albert Einstein College of Medicine
Rutgers, The State University of New Jersey
TuHURA Biosciences, Inc.
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
University of Arkansas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Wake Forest University Health Sciences
Boston Scientific Corporation
Daiichi Sankyo